Original research
by
Burns, Marguerite et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
This study measured the association between MOUD continuation, relative to discontinuation, and opioid-related overdose among Medicaid beneficiaries.
Findings/Key points
Continuation of medication for opioid use disorder (MOUD) in US Medicaid beneficiaries was associated with a substantial reduction in overdose risk up to 12 months after the first claim for MOUD.
Design/methods
Retrospective cohort study in 11 US states (n=293,180)
Keywords
Overdose
About PWUD
Transitions in care/treatment
Outcomes
